vHospital

VHOSPITAL.CLINIC · Drug Reference

Hormonal AnticancerPrescription Only

Leuprorelin Side Effects

Like all medications, Leuprorelin can cause side effects. Most people do not experience serious adverse effects, but it is important to know what to look for and when to seek medical care.

Common Side Effects

  • Nausea or GI discomfort
  • Headache
  • Fatigue
  • Dizziness

Serious Side Effects

  • Severe allergic reaction
  • Organ toxicity (specific to drug class)
  • Drug-specific serious adverse effects

When to Seek Medical Care

  • Signs of allergic reaction (rash, swelling, breathing difficulty)
  • Severe or unexpected side effects
  • Unusual symptoms during treatment

Safety Note

If you experience any unexpected or concerning symptoms while taking Leuprorelin, contact your doctor or pharmacist. Do not stop taking Leuprorelin without medical advice unless you experience a serious adverse reaction.

Frequently Asked Questions

Are side effects from Leuprorelin common?

Most patients tolerate Leuprorelin well at therapeutic doses. Common side effects are usually mild and often improve after the first few weeks. Serious side effects are less common but should be reported immediately.

What should I do if I experience side effects from Leuprorelin?

Mild side effects: discuss with your pharmacist, as many resolve spontaneously. Serious side effects: seek medical care immediately and contact your prescriber. Do not stop Leuprorelin abruptly for long-term conditions without medical advice.

More About Leuprorelin

Have Questions About Leuprorelin?

Describe your symptoms and concerns and get a structured clinical assessment — possible causes, red flags, and recommended next steps.

Start Free AI Analysis →

Medical Disclaimer: This drug reference is provided for informational purposes only and is not a substitute for professional medical advice. Always consult your physician or pharmacist before changing your medication. Information reviewed by the vHospital Editorial Team · Sources: WHO, BNF, FDA prescribing information.